Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 4/20 | 0.57 |
| ▸ | HTR2A | P28223 | 11/20 | 0.56 |
| ▸ | HTR2C | P28335 | 6/20 | 0.56 |
| ▸ | HTR2B | P41595 | 6/20 | 0.56 |
| ▸ | HTR1A | P08908 | 5/20 | 0.56 |
| ▸ | HTR1B | P28222 | 3/20 | 0.50 |
| ▸ | HTR7 | P34969 | 2/20 | 0.50 |
| ▸ | HTR5A | P47898 | 2/20 | 0.50 |
| ▸ | HTR1D | P28221 | 2/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | HTR1E | P28566 | 1/20 | 0.50 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.50 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | HTR1F | P30939 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.42 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25074532 | 1.00 | HTR6 (0.57) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL30249024 | 0.96 | HTR6 (0.55) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL31320742 | 0.96 | HTR6 (0.55) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL25074534 | 0.96 | HTR6 (0.55) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL25074527 | 0.96 | HTR6 (0.55) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL29259496 | 0.93 | HTR6 (0.65) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL25074599 | 0.91 | HTR6 (0.58) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL25074645 | 0.89 | HTR6 (0.64) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL25074596 | 0.89 | HTR2A (0.62) | HTR6HTR2AHTR2CHTR2BHTR1A | |
| SCHEMBL31666427 | 0.87 | HTR6 (0.61) | HTR6HTR2AHTR2CHTR2BHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250011344-A1 | PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF | TERRAN BIOSCIENCES INC (US) | 2025-01-09 | — | — | US | disclosed |
| CN-118119389-A | Prodrugs and derivatives of des-phosphate nupharicin and uses thereof | 人类生物科学股份有限公司 | 2024-05-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250011344-A1 | PRODRUGS AND DERIVATIVES OF PSILOCIN AND USES THEREOF | PSAP, PIGO, PSAT1 | HTR6 510/4885HTR2A 668/4885HTR2C 1317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.